Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes
Clinical trial NCT05139914 · TERMINATED
Trial details
- NCT number
- NCT05139914
- Sponsor
- Boston University
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-31
- Primary completion
- 2025-02-04
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.